PharmAust (ASX: PAA) executive chairman and CEO Dr Roger Aston joins Small Caps to discuss the latest news in relation to its lead drug...

PharmAust (ASX: PAA) ready to trial monepantel on humans to fight motor neurone disease (w/ Dr Roger Aston)

<p>Small Caps is Australia's #1 site for investor news &amp; information on ASX listed small cap companies. The podcast keeps investors informed by showcasing interviews with directors of ASX listed small cap companies and financial market analysts. For more information visit: https://smallcaps.com.au/.</p>

Business

News

Investing

Business News

Small Caps is Australia's #1 site for investor news & information on ASX listed small cap companies. The podcast keeps investors informed by showcasing interviews with directors of ASX listed small cap companies and financial market analysts. For more information visit: https://smallcaps.com.au/.

Share PharmAust (ASX: PAA) ready to trial monepantel on humans to fight motor neurone disease (w/ Dr Roger Aston)

Sign up to save your podcasts

PharmAust (ASX: PAA) ready to trial monepantel on humans to fight motor neurone disease (w/ Dr Roger Aston)

PharmAust (ASX: PAA) ready to trial monepantel on humans to fight motor neurone disease (w/ Dr Roger Aston)

More shows like Small Caps

CommSec Market Update

Motley Fool Money

NAB Morning Call

The Money Puzzle

Equity Mates Investing Podcast

The Rules of Investing

Your Wealth

Australian Investors Podcast

Australian Finance Podcast

Money of Mine

Get Started Investing

Buy Hold Sell, by Livewire Markets

The Call from ausbiz

The Money Café with Alan Kohler

Chanticleer